Your browser doesn't support javascript.
loading
The approval of vedolizumab for the management of inflammatory bowel diseases in brazil: the beginning of a new biological era
Kotze, Paulo Gustavo; Damião, Aderson Omar Mourão Cintra; Moraes, Antonio Carlos.
Affiliation
  • Kotze, Paulo Gustavo; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR
  • Damião, Aderson Omar Mourão Cintra; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR
  • Moraes, Antonio Carlos; PUCPR. Hospital Universitário Cajuru. Serviço de Coloproctologia. Curitiba. BR
Arq. gastroenterol ; 53(1): 3-4, Jan.-Mar. 2016.
Article in En | LILACS | ID: lil-777111
Responsible library: BR1.1

Full text: 1 Index: LILACS Main subject: Colitis, Ulcerative / Crohn Disease / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Arq. gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2016 Type: Article

Full text: 1 Index: LILACS Main subject: Colitis, Ulcerative / Crohn Disease / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Arq. gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2016 Type: Article